Form 8-K - Current report:
SEC Accession No. 0001193125-20-100902
Filing Date
2020-04-08
Accepted
2020-04-08 08:00:32
Documents
1
Period of Report
2020-04-02
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K d915549d8k.htm 8-K 17513
  Complete submission text file 0001193125-20-100902.txt   18782
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

EIN.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32587 | Film No.: 20781116
SIC: 2834 Pharmaceutical Preparations